TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 7 | -2 | 5 | 13 | -17 | -18 | -20 | -6 |
| S | %wins | 71 | 29 | 29 | 86 | 71 | 71 | 60 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/6/16 18:51 | 1/5/16 | NLNK | Newlink Genetics Corp | Health | Drug | Pharmaceutical Preparations | Wiley Brian | IA | O | VP of Bu | S.d | -45 | 34.99 | 14 | -1 | -6 | 20 | D | 56 | -17 | -24 | -6 | -5 | 5 | -7 | -6 | -8 | -12 | -20 | -37 | -60 | -62 | |
3/4/15 18:27 | 3/2/15 | NLNK | Newlink Genetics Corp | Health | Drug | Pharmaceutical Preparations | Wiley Brian | IA | O | VP of Bu | S.d | -899 | 44.93 | 18 | -20 | -57 | 15 | D | 294 | 18 | 67 | 18 | 18 | 29 | 16 | 10 | -1 | 1 | 10 | -13 | -10 | -64 | |
2/19/15 16:49 | 2/17/15 | NLNK | Newlink Genetics Corp | Health | Drug | Pharmaceutical Preparations | Wiley Brian | IA | O | VP of Bu | S.d | -401 | 40.07 | 15 | -10 | -40 | 15 | D | 235 | 0 | 47 | 35 | 9 | 6 | 27 | 11 | -3 | 0 | 36 | -1 | 25 | -49 | |
1/6/15 20:36 | 1/2/15 | NLNK | Newlink Genetics Corp | Health | Drug | Pharmaceutical Preparations | Wiley Brian | IA | O | VP of Bu | S.d | -807 | 40.33 | 18 | -20 | -59 | 14 | D | 245 | 88 | 55 | 76 | 24 | 16 | 10 | 6 | 0 | 7 | -15 | 38 | 17 | -9 | |
2/5/14 18:15 | 2/3/14 | NLNK | Newlink Genetics Corp | Health | Drug | Pharmaceutical Preparations | Wiley Brian | IA | O | VP of Bu | S.d | -728 | 36.41 | 20 | -20 | -75 | 7 | D | 436 | 201 | 107 | 110 | 63 | 37 | 12 | 1 | 2 | 19 | 6 | -38 | -35 | -10 | |
1/23/14 16:57 | 1/21/14 | NLNK | Newlink Genetics Corp | Health | Drug | Pharmaceutical Preparations | Wiley Brian | IA | O | VP of Bu | S.dm | -528 | 35.22 | 14 | -15 | -69 | 7 | D | 399 | 188 | 92 | 99 | 63 | 56 | 38 | 13 | -3 | 4 | 37 | -32 | -34 | 16 | |
1/15/14 20:58 | 1/13/14 | NLNK | Newlink Genetics Corp | Health | Drug | Pharmaceutical Preparations | Wiley Brian | IA | O | VP of Bu | S.dm | -552 | 27.59 | 7 | -20 | -75 | 7 | D | 289 | 128 | 47 | 40 | 25 | 16 | 22 | 15 | 2 | 17 | 39 | -38 | -31 | 40 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |